Osteoarthritis (OA) is a most common chronic degenerative joint disease, affecting weight bearing joints. It gradually leads to a disability restricting the individual from various daily functional activities. It is a combination of mechanical abnormalities characterized by degradation of articular cartilage, articulating joints and subchondral space. This damage to articular cartilage leads to fibrillation, fissures, gross ulcerations and finally disappearance of the full thickness of articular
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1: Patients between 45-65 years of age and suffering from knee pain for more than 3 months. Osteoarthritis confirmed by radiographic imaging, Grade I and II according to Kllegren and Lawrence classification of knee Osteoarthritis. Unilateral knee osteoarthritis. Both males and females are included in the study
Exclusion criteria
Exclusion criteria: • Patients suffering from degenerative diseases of other lower extremity joints. • Recent fractures. • Vertigo • Chronic heart disease. • Patients having other musculoskeletal problems with Red flag signs For instance: Osteoporosis, Paget’s disease, Rheumatoid arthritis. • Prolonged immobilization. • Patients having neurological deficits/Hemiplegics. • Osteoarthritis of Bilateral knee joint. • Patients who are not able to ambulate without assistive device or aid. • Patients who have received knee surgery in past 3 months. • Patients who have received intra-articular injection in last 6 weeks prior to study are excluded from research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Balance. Timepoint: Before treatment, after 2 weeks, after 4 weeks at the end of treatment. Method of measurement: Dynamic y balance test.;Range of motion. Timepoint: Before treatment, after 2 weeks, after 4 weeks at the end of treatment. Method of measurement: Goniometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain intensity. Timepoint: Before treatment, after 2 weeks, after 4 weeks at the end of treatment. Method of measurement: Visual analogue scale. | — |
Countries
Pakistan
Contacts
Riphah international university